PENBRAYA Trademark

Trademark Overview

On Thursday, October 6, 2022, a trademark application was filed for PENBRAYA with the United States Patent and Trademark Office. The USPTO has given the PENBRAYA trademark a serial number of 97621374. The federal status of this trademark filing is REGISTERED as of Tuesday, May 7, 2024. This trademark is owned by Pfizer Inc.. The PENBRAYA trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines for human use
penbraya

General Information

Serial Number97621374
Word MarkPENBRAYA
Filing DateThursday, October 6, 2022
Status700 - REGISTERED
Status DateTuesday, May 7, 2024
Registration Number7382222
Registration DateTuesday, May 7, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 22, 2023

Trademark Statements

Goods and ServicesVaccines for human use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, October 11, 2022
Primary Code005
First Use Anywhere DateMonday, January 15, 2024
First Use In Commerce DateMonday, January 15, 2024

Trademark Owner History

Party NamePfizer Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNew York, NY 10001-2192
Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10001-2192
Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 100012192

Trademark Events

Event DateEvent Description
Monday, October 10, 2022NEW APPLICATION ENTERED
Tuesday, October 11, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 28, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, March 28, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 28, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, July 7, 2023ASSIGNED TO EXAMINER
Friday, July 14, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 2, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 22, 2023PUBLISHED FOR OPPOSITION
Tuesday, August 22, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 17, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, March 13, 2024TEAS STATEMENT OF USE RECEIVED
Wednesday, April 3, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, March 13, 2024USE AMENDMENT FILED
Wednesday, April 3, 2024STATEMENT OF USE PROCESSING COMPLETE
Thursday, April 4, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, April 5, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, May 7, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, May 7, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Friday, January 30, 2026TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, January 30, 2026ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, January 30, 2026TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, January 30, 2026TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

Related Keywords

penbraya human vaccines